Human nasal mucosa contains tissue-resident immunologically responsive mesenchymal stromal cells

Stem Cells and Development

Volumn 19, Issue 5, 2010, Pages 635-644

  Jakob, Mark ^a,b   Hemeda, Hatim ^a   Janeschik, Sandra ^a   Bootz, Friedrich ^b   Rotter, Nicole ^c   Lang, Stephan ^a   Brandau, Sven ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; BETA1 INTEGRIN; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CHEMOKINE RECEPTOR CXCR6; CHEMOKINE RECEPTOR CXCR7; ENDOGLIN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; THY 1 ANTIGEN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CYTOKINE;

ADIPOCYTE; ADULT; ARTICLE; BONE CELL; CARTILAGE CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MUCOSAL IMMUNITY; MULTIPOTENT STEM CELL; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE REPAIR; BIOSYNTHESIS; CELL ADHESION; CELL PROLIFERATION; CELL SEPARATION; CELL SHAPE; CULTURE TECHNIQUE; CYTOLOGY; IMMUNOLOGY; MESENCHYMAL STROMA CELL; PROCEDURES;

BIOLOGICAL MARKERS; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELL SHAPE; CYTOKINES; HUMANS; MESENCHYMAL STROMAL CELLS; MULTIPOTENT STEM CELLS; NASAL MUCOSA;

EID: 77952935878     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0245     Document Type: Article

References (43)

1. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
2. Horwitz EM, K Le Blanc, M Dominici, I Mueller, I Slaper-Cortenbach, FC Marini, RJ Deans, DS Krause and A Keating. (2005). Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7:393-395.
3. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for def ning multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
4. Wagner W, F Wein, A Seckinger, M Frankhauser, U Wirkner, U Krause, J Blake, C Schwager, V Eckstein, W Ansorge and AD Ho. (2005). Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33:1402-1416.
5. Lin TM, HW Chang, KH Wang, AP Kao, CC Chang, CH Wen, CS Lai and SD Lin. (2007). Isolation and identification of mesenchymal stem cells from human lipoma tissue. Biochem Biophys Res Commun 361:883-889.
6. Soncini M, E Vertua, L Gibelli, F Zorzi, M Denegri, A Albertini, GS Wengler and O Parolini. (2007). Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med 1:296-305.
7. Rotter N, J Oder, P Schlenke, U Lindner, F Bohrnsen, J Kramer, J Rohwedel, R Huss, S Brandau, B Wollenberg and S Lang. (2008). Isolation and characterization of adult stem cells from human salivary glands. Stem Cells Dev 17:509-518.
8. Keating A. (2006). Mesenchymal stromal cells. Curr Opin Hematol 13:419-425.
9. Uccelli A, L Moretta and V Pistoia. (2006). Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 36:2566-2573. (Pubitemid 44608440)
10. Honczarenko M, Y Le, M Swierkowski, I Ghiran, AM Glodek and LE Silberstein. (2006). Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24:1030-1041.
11. Ji JF, BP He, ST Dheen and SS Tay. (2004). Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 22:415-427.
12. Tyndall A, UA Walker, A Cope, F Dazzi, BC De, W Fibbe, S Guiducci, S Jones, C Jorgensen, K Le Blanc, F Luyten, D McGonagle, I Martin, C Bocelli-Tyndall, G Pennesi, V Pistoia, C Pitzalis, A Uccelli, N Wulffraat and M Feldmann. (2007). Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther 9:301.
13. Rainaldi G, B Pinto, A Piras, L Vatteroni, S Simi and L Citti. (1991). Reduction of proliferative heterogeneity of CHEF18 Chinese hamster cell line during the progression toward tumorigenicity. in Vitro Cell Dev Biol 27A:949-952.
14. Conget PA and JJ Minguell. (1999). Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 181:67-73.
15. Baksh D, L Song and RS Tuan. (2004). Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8:301-316.
16. Kassem M, M Kristiansen and BM Abdallah. (2004). Mesenchymal stem cells: cell biology and potential use in therapy. Basic Clin Pharmacol Toxicol 95:209-214.
17. Abdallah BM and M Kassem. (2008). Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther 15:109-116.
18. Lorenz K, M Sicker, E Schmelzer, T Rupf, J Salvetter, M Schulz-Siegmund and A Bader. (2008). Multilineage differentiation potential of human dermal skin-derived f broblasts. Exp Dermatol 17:925-932.
19. Haniffa MA, XN Wang, U Holtick, M Rae, JD Isaacs, AM Dickinson, CM Hilkens and MP Collin. (2007). Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol 179:1595-1604.
20. Haniffa MA, MP Collin, CD Buckley and F Dazzi. (2009). Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica 94:258-263.
21. Colter DC, R Class, CM DiGirolamo and DJ Prockop. (2000). Rapid expansion of recycling stem cells in cultures of plasticadherent cells from human bone marrow. Proc Natl Acad Sci USA 97:3213-3218.
22. Pochampally R. (2008). Colony forming unit assays for MSCs. Methods Mol Biol 449:83-91.
23. Wexler SA, C Donaldson, P ning-Kendall, C Rice, B Bradley and JM Hows. (2003). Adult bone marrow is a rich source of human mesenchymal "stem" cells but umbilical cord and mobilized adult blood are not. Br J Haematol 121:368-374.
24. Galmiche MC, VE Koteliansky, J Briere, P Herve and P Charbord. (1993). Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood 82:66-76.
25. Buhring HJ, VL Battula, S Treml, B Schewe, L Kanz and W Vogel. (2007). Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci 1106:262-271.
26. Ozaki K, K Sato, I Oh, A Meguro, R Tatara, K Muroi and K Ozawa. (2007). Mechanisms of immunomodulation by mesenchymal stem cells. Int J Hematol 86:5-7.
27. Rasmusson I. (2006). Immune modulation by mesenchymal stem cells. Exp Cell Res 312:2169-2179.
28. Krampera M, S Glennie, J Dyson, D Scott, R Laylor, E Simpson and F Dazzi. (2003). Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101:3722-3729.
29. Nasef A, N Ashammakhi and L Fouillard. (2008). Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms. Regen Med 3:531-546.
30. Jiang XX, Y Zhang, B Liu, SX Zhang, Y Wu, XD Yu and N Mao. (2005). Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105:4120-4126.
31. Deng W, Q Han, L Liao, S You, H Deng and RC Zhao. (2005). Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice. DNA Cell Biol 24:458-463.
32. Le Blanc K, I Rasmusson, B Sundberg, C Gotherstrom, M Hassan, M Uzunel and O Ringden. (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441.
33. Sudres M, F Norol, A Trenado, S Gregoire, F Charlotte, B Levacher, JJ Lataillade, P Bourin, X Holy, JP Vernant, D Klatzmann and JL Cohen. (2006). Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J Immunol 176:7761-7767.
34. Calandra T and T Roger. (2003). Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3:791-800. (Pubitemid 37328657)
35. Schorr W, D Swandulla and HU Zeilhofer. (1999). Mechanisms of IL-8-induced Ca2+ signaling in human neutrophil granulocytes. Eur J Immunol 29:897-904.
36. Chamberlain G, J Fox, B Ashton and J Middleton. (2007). Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739-2749.
37. Croitoru-Lamoury J, FM Lamoury, JJ Zaunders, LA Veas and BJ Brew. (2007). Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone. J Interferon Cytokine Res 27:53-64.
38. Caplan AI and JE Dennis. (2006). Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076-1084.
39. Thomas J, F Liu and DC Link. (2002). Mechanisms of mobilization of hematopoietic progenitors with granulocyte colonystimulating factor. Curr Opin Hematol 9:183-189.
40. Sordi V, ML Malosio, F Marchesi, A Mercalli, R Melzi, T Giordano, N Belmonte, G Ferrari, BE Leone, F Bertuzzi, G Zerbini, P Allavena, E Bonifacio and L Piemonti. (2005). Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106:419-427.
41. Wynn RF, CA Hart, C Corradi-Perini, L O'Neill, CA Evans, JE Wraith, LJ Fairbairn and I Bellantuono. (2004). A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104:2643-2645.
42. von Lüttichau I, M Notohamiprodjo, A Wechselberger, C Peters, A Henger, C Seliger, R Djafarzadeh, R Huss and PJ Nelson. (2005). Human adult. Stem Cells Dev 14:329-336.
43. Kumar S, D Chanda and S Ponnazhagan. (2008). Therapeutic potential of genetically modif ed mesenchymal stem cells. Gene Ther 15:711-715.